Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Masahiko, Umei"'
Autor:
Satoshi Bujo, Haruhiro Toko, Kaoru Ito, Satoshi Koyama, Masato Ishizuka, Masahiko Umei, Haruka Yanagisawa-Murakami, Jiaxi Guo, Bowen Zhai, Chunxia Zhao, Risa Kishikawa, Norifumi Takeda, Kensuke Tsushima, Yuichi Ikeda, Eiki Takimoto, Hiroyuki Morita, Mutsuo Harada, Issei Komuro
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract Cardiovascular disease (CVD) is a global health burden in the world. Although low-carbohydrate diets (LCDs) have beneficial effects on CVD risk, their preventive effects remain elusive. We investigated whether LCDs ameliorate heart failure (
Externí odkaz:
https://doaj.org/article/48ca2affdf77439ca88ffad8353c678a
Autor:
Masahiko Umei, MD, Mikio Kishi, MD, Takahiro Sato, MD, PhD, Akito Shindo, MD, Masayuki Toyoda, MD, Masaaki Yokoyama, MD, Masashiro Matsushita, MD, Satoshi Ohnishi, MD, Masao Yamasaki, MD, PhD
Publikováno v:
Journal of Arrhythmia, Vol 33, Iss 5, Pp 475-482 (2017)
Background: Direct oral anticoagulants (DOACs) have been developed for stroke prevention in patients with non-valvular atrial fibrillation (NVAF). We conducted a retrospective cohort study of patients with NVAF who were newly treated with DOACs in a
Externí odkaz:
https://doaj.org/article/11c0572f0ec94b328c4e4bdcaf21a84f
Autor:
Atsushi Yao, Masahiko Umei, Masae Uehara, Katsura Soma, Issei Komuro, Akihito Saito, Toshiro Inaba
Publikováno v:
Internal Medicine. 61:851-855
The closure of small/coincidental atrial septal defects (ASDs) in patients with pulmonary arterial hypertension (PAH) has been described in recent major guidelines as useless or even contraindicated. We confirm the effectiveness of "Treat and Repair"
Autor:
Masahiko Umei, Hiroshi Akazawa, Akiko Saga-Kamo, Hiroki Yagi, Qing Liu, Ryo Matsuoka, Hiroshi Kadowaki, Akito Shindo, Ayaka Nakashima, Kosuke Yasuda, Kengo Suzuki, Issei Komuro
Publikováno v:
Circulation Reports. 4:83-91
Autor:
Hiroki Yagi, Hiroshi Akazawa, Qing Liu, Masahiko Umei, Hiroshi Kadowaki, Ryo Matsuoka, Akito Shindo, Shun Okamura, Akiko Saga-Kamo, Norifumi Takeda, Issei Komuro
BackgroundMarfan syndrome (MFS), an inherited disorder caused byFBN1gene mutations, causes fatal aortic aneurysm. Selective angiotensin II (Ang II) type 1 (AT1) receptor blockade is a preventive option for patients with MFS aortopathy, and recent cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bc54ae40f8f152e06066a98e01ad0d0
https://doi.org/10.1101/2022.12.21.521508
https://doi.org/10.1101/2022.12.21.521508
Autor:
Hiroshi Akazawa, Yusuke Sato, Junichi Ishida, Issei Komuro, Hiroshi Matsunaga, Hiroki Yagi, Hiroshi Kadowaki, Akiko Saga-Kamo, Ryo Matsuoka, Haruki Kume, Hisataka Maki, Qing Liu, Masahiko Umei
Publikováno v:
Circulation Reports
Background: Axitinib is a tyrosine kinase inhibitor (TKI) that inhibits vascular endothelial growth factor receptor signaling and is approved for second-line treatment of advanced renal cell carcinoma (RCC). Although the occurrence of hypertension wi
Autor:
Ryo Matsuoka, Hiroshi Akazawa, Satoshi Kodera, Katsura Soma, Hiroki Yagi, Masahiko Umei, Hiroshi Kadowaki, Junichi Ishida, Hiroki Shinohara, Susumu Katsushika, Hirotaka Ieki, Toshihiro Yamaguchi, Yasutomi Higashikuni, Katsuhito Fujiu, Kaoru Ito, Atsushi Yao, Issei Komuro
Many patients with atrial septal defects (ASD) are asymptomatic and undiagnosed during the first few decades of life, but have overt heart failure, arrhythmias, cerebral infarction, and increased mortality in adults with advancing age. To provide a n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::472a0c9241bf9ab5c842efdbb5e4ff82
https://doi.org/10.1101/2022.01.30.22270137
https://doi.org/10.1101/2022.01.30.22270137
Autor:
Hiroki Yagi, Hiroshi Akazawa, Qing Liu, Kimiko Yamamoto, Kan Nawata, Akiko Saga-Kamo, Masahiko Umei, Hiroshi Kadowaki, Ryo Matsuoka, Akito Shindo, Haruhiro Toko, Norifumi Takeda, Masahiko Ando, Haruo Yamauchi, Norihiko Takeda, Mehdi A. Fini, Minoru Ono, Issei Komuro
Marfan syndrome (MFS) is an inherited connective tissue disorder caused by mutations in the FBN1 gene encoding fibrillin-1, a matrix component of extracellular microfibrils. The main cause of morbidity and mortality in MFS is thoracic aortic aneurysm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae4e76b6853e6273df298534472e62e4
https://doi.org/10.1101/2022.01.30.478356
https://doi.org/10.1101/2022.01.30.478356
Autor:
Masahiko, Umei, Hiroshi, Akazawa, Akiko, Saga-Kamo, Hiroki, Yagi, Qing, Liu, Ryo, Matsuoka, Hiroshi, Kadowaki, Akito, Shindo, Ayaka, Nakashima, Kosuke, Yasuda, Kengo, Suzuki, Issei, Komuro
Publikováno v:
Circulation reports. 4(2)
Autor:
Hiroshi Kadowaki, Seitaro Nomura, Issei Komuro, Hiroshi Matsunaga, Qing Liu, Hiroshi Akazawa, Hiroki Yagi, Akiko Saga-Kamo, Masahiko Umei, Ryo Matsuoka
Publikováno v:
European Heart Journal. 41
Introduction Short-chain fatty acids are one of the gut microbial metabolites that may influence host physiology. We previously reported that gut dysbiosis was associated with heart failure, and that the proportions of butyrate-producing bacteria dim